Organic compounds

The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmo...

Full description

Saved in:
Bibliographic Details
Main Authors SINGH, DILRAJ, MAAS, JANET C, HARRIS, JENNIFER LESLIE, MONNIER, STEPHANIE, HEUERDING, SILVIA, REBER, JEAN-LOUIS, ROETTELE, JUERGEN, TULLY, DAVID C, DANAHAY, HENRY L, LEGRAND, DARREN M
Format Patent
LanguageEnglish
French
German
Published 06.04.2011
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
Bibliography:Application Number: EP20100184992